Alzheimers disease therapy (Senex)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAlzheimers disease therapy (Senex)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitorsProtein-glutamine gamma-glutamyltransferase inhibitorsBeta amyloid A4 protein aggregation inhibitors
TargetsBeta-secretase 1Beta amyloid A4 proteinProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSenex Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSenex Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A